Revolade® 75 mg film-coated tablets – patient leaflet, side effects, dosage

1. What Revolade is and what it is used for

Revolade contains eltrombopag, which belongs to a group of medicines called thrombopoietin- receptor agonists. It is used to help increase the number of platelets in your blood. Platelets are blood cells that help to reduce or prevent bleeding.

• Revolade is used to treat a

  bleeding disorder called immune (primary) thrombocytopenia (ITP) in patients aged 1 year and above who have already taken other medicines (corticosteroids or immunoglobulins), which have not worked.

  ITP is caused by a low

  blood platelet count

  (thrombocytopenia). People with ITP have an increased risk of bleeding. Symptoms patients with ITP may notice include petechiae (pinpoint-sized flat round red spots under the skin), bruising, nosebleeds, bleeding gums and not being able to control bleeding if they are cut or injured.

• Revolade can also be used

  to treat low platelet count (thrombocytopenia) in adults with hepatitis C virus (HCV) infections, if they have had problems with side effects while on interferon treatment. Many people with hepatitis C have low platelet counts, not only as a result of the disease, but also due to some of the antiviral medicines that are used to treat it. Taking Revolade may make it easier for you to complete a full course of antiviral medicine (peginterferon and ribavirin).

• Revolade may also be used to

  è Read the information ‘Liver problems’ in section 4 of this leaflet. Blood tests for platelet count

  If you stop taking Revolade, your blood platelet count is likely to become low again within several days. The platelet count will be monitored, and your doctor will discuss appropriate precautions with you.

  A very high blood platelet count may increase the risk of blood clotting. However blood clots can also form with normal or even low platelet counts. Your doctor will adjust your dose of Revolade to ensure that your platelet count does not become too high.

  Get medical help immediately if you have any of these signs of a blood clot:

  • swelling, pain or tenderness in

    one leg

  • sudden shortness of breath

    especially together with sharp pain in the chest or rapid breathing

  • abdominal (stomach) pain, enlarged

    abdomen, blood in your stools Tests to check your bone marrow

In people who have problems with their bone marrow, medicines like Revolade could make the problems worse. Signs of bone marrow changes may show up as abnormal results in your blood tests. Your doctor may also carry out tests to directly check your bone marrow during treatment with Revolade.

Checks for digestive bleeding

If you are taking interferon-based treatments together with Revolade you will be monitored for any signs of bleeding in your stomach or intestine after you stop taking Revolade. Heart monitoring

Your doctor may consider it necessary to monitor your heart during treatment with Revolade and carry out an electrocardiogram (ECG) test.

Older people (65 years and above)

There are limited data on the use of Revolade in patients aged 65 years and older. Care should be taken when using Revolade if you are aged 65 years or above.

Children and adolescents

Revolade is not recommended for children aged under 1 year who have ITP. It is also not recommended for people under 18 years with low platelet counts due to hepatitis C or severe aplastic anaemia.

Other medicines and Revolade

Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. This includes medicines obtained without prescription and vitamins.

Some everyday medicines interact with Revolade – including prescription and non-prescription medicines and minerals. These include:

• antacid medicines to treat

  indigestion, heartburn or stomach ulcers (see also ‘When to take it’ in section 3)

• medicines called statins, to lower

  cholesterol

• some medicines to treat HIV

  infection, such as lopinavir and/or ritonavir

• ciclosporin used in the context

  of transplantations or immune diseases

• minerals such as iron, calcium,

  magnesium, aluminium, selenium and zinc which may be found in vitamin and mineral supplements

  (see also ‘When to take it’ in section 3)

• medicines such as methotrexate and

  topotecan, to treat cancer

è Talk to your doctor if you take any

of these. Some of them are not to be taken with Revolade, or the dose may need adjusting, or you may need to alter the timing of when you take them. Your doctor will review the medicines you are taking, and suggest suitable replacements if necessary.

treat adult patients with low blood counts caused by severe aplastic anaemia (SAA). SAA is a disease in which the bone marrow is damaged, causing a deficiency of the red blood cells (anaemia), white blood cells (leukopenia) and platelets (thrombocytopenia).

2. What you need to know before you take Revolade

Do not take Revolade

• if you are allergic to eltrombopag or

  any of the other ingredients of this medicine (listed in section 6 under ‘What Revolade contains’).

  è Check with your doctor if you

  think this applies to you.

Warnings and precautions

Talk to your doctor before taking Revolade:

• if you have liver problems. People

  who have low platelet counts as well as advanced chronic (long-term) liver disease are more at risk of side effects, including life-threatening liver damage and blood clots. If your doctor considers that the benefits of taking Revolade outweigh the risks, you will be closely monitored during treatment.

• if you are at risk of blood clots in

  your veins or arteries, or you know that blood clots are common in your family.

  You may be at higher risk of blood clots:

  • as you get older

  • if you have had to stay in bed for

    a long time

  • if you have cancer

  • if you are taking the contraceptive

    birth control pill or hormone replacement therapy

  • if you have recently had surgery

    or received a physical injury

  • if you are very overweight (obese)
  • if you are a smoker

  • if you have advanced chronic liver

    disease

è If any of these apply to you,

tell your doctor before starting treatment. You should not take Revolade unless your doctor considers that the expected benefits outweigh the risk of blood clots.

• if you have cataracts (the lens of the

  eye getting cloudy)

• if you have another blood condition,

  such as myelodysplastic syndrome (MDS). Your doctor will carry out tests to check that you do not have this blood condition before you start Revolade. If you have MDS and take Revolade, your MDS may get worse. è Tell your doctor if any of these

  apply to you.

Eye examinations

Your doctor will recommend that you are checked for cataracts. If you do not have routine eye-tests your doctor should arrange regular testing. You may also be checked for the occurrence of any bleeding in or around your retina (the light-sensitive layer of cells at the back of the eye).

You will need regular tests

Before you start taking Revolade, your doctor will carry out blood tests to check your blood cells, including platelets. These tests will be repeated at intervals while you are taking it. Blood tests for liver function

Revolade can cause blood test results that may be signs of liver damage - an increase of some liver enzymes, especially bilirubin and alanine / aspartate transaminases. If you are taking interferon-based treatments together with Revolade to treat low platelet count due to hepatitis C, some liver problems can get worse. You will have blood tests to check your liver function before you start taking Revolade and at intervals while you are taking it. You may need to stop taking Revolade if the amount of these substances increases too much, or if you get other signs of liver damage.

If you are also taking medicines to prevent blood clots there is a greater risk of bleeding. Your doctor will discuss this with you.

If you are taking corticosteroids, danazol, and/or azathioprine you may need to take a lower dose or to stop taking them while you are taking Revolade.

Revolade with food and drink

Do not take Revolade with dairy foods or drinks as the calcium in dairy products affects the absorption of the medicine. For more information, see ‘When to take it’ in section 3.

Pregnancy and breast-feeding Don’t use Revolade if you are pregnant

unless your doctor specifically recommends it. The effect of Revolade during pregnancy is not known.

• Tell your doctor if you are pregnant,

  think you may be pregnant, or are planning to have a baby.

• Use a reliable method of

  contraception while you’re taking Revolade, to prevent pregnancy

• If you do become pregnant during

  treatment with Revolade, tell your doctor.

Don’t breast-feed while you are taking Revolade. It is not known whether Revolade passes into breast-milk. è If you are breast-feeding or planning

to breast-feed, tell your doctor. Driving and using machines

Revolade can make you dizzy and have other side effects that make you less alert.

è Don’t drive or use machines unless

you are sure you’re not affected. Revolade contains sodium

This medicine contains less than 1 mmol sodium (23 mg) per tablet, that is to say essentially ‘sodium-free’.

3. How to take Revolade

Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure. Do not change the dose or schedule for taking Revolade unless your doctor or pharmacist advises you to. While you are taking Revolade, you will be under the care of a doctor with specialist experience in treating your condition.

How much to take

For ITP

Adults and children (6 to 17 years) – the usual starting dose for ITP is one 50 mg tablet of Revolade a day. If you are of East-/Southeast-Asian origin you may need to start at a lower dose of 25 mg. Children (1 to 5 years) — the usual starting dose for ITP is one 25 mg tablet of Revolade a day.

For hepatitis C

Adults - the usual starting dose for hepatitis C is one 25 mg tablet of Revolade a day. If you are of

East-/Southeast-Asian origin you will start on the same 25 mg dose. For SAA

Adults - the usual starting dose for SAA is one 50 mg tablet of Revolade a day. If you are of East-/Southeast-Asian origin you may need to start at a lower dose of 25 mg.

Revolade may take 1 to 2 weeks to work. Based on your response to Revolade your doctor may recommend that your daily dose is changed. How to take the tablets

Swallow the tablet whole, with some water.

When to take it

Make sure that –

• in the 4 hours before you take

  Revolade

• and the 2 hours after you take

  Revolade

  you don’t consume any of the following:

  • dairy foods such as cheese, butter,

    yoghurt or ice cream

  • milk or milk shakes, drinks

    containing milk, yoghurt or cream

  • antacids, a type of medicine for

    indigestion and heartburn

  • some mineral and vitamin

    supplements including iron, calcium, magnesium, aluminium, selenium and zinc

If you do, the medicine will not be properly absorbed into your body.

For more advice about suitable foods and drinks, talk to your doctor. If you take more Revolade than you should

Contact a doctor or pharmacist immediately. If possible show them the pack, or this leaflet.

You will be monitored for any signs or symptoms of side effects and given appropriate treatment immediately. If you forget to take Revolade

Take the next dose at the usual time. Do not take more than one dose of Revolade in one day.

If you stop taking Revolade

Don’t stop taking Revolade without talking to your doctor. If your doctor advises you to stop treatment, your platelet count will then be checked each week for four weeks. See also ‘Bleeding or bruising after you stop treatment’ in section 4.

If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Symptoms needing attention: see a doctor

People taking Revolade for either ITP or low blood platelet counts due to hepatitis C could develop signs of potentially serious side effects. It is important to tell a doctor if you develop these symptoms.

Higher risk of blood clots

Certain people may have a higher risk of blood clots, and medicines like Revolade could make this problem worse. The sudden blocking of a blood vessel by a blood clot is an uncommon side effect and may affect up to 1 in 100 people.

Get medical help immediately if you develop signs and symptoms of a blood clot, such as:

• swelling, pain, heat, redness, or

  tenderness in one leg

• sudden shortness of breath,

  especially together with sharp pain in the chest or rapid breathing

• abdominal (stomach) pain, enlarged

  abdomen, blood in your stools. Liver problems

Revolade can cause changes that show up in blood tests, and may be signs of liver damage. Liver problems (increased enzymes showing up in blood tests) are common and may affect up to 1 in 10 people. Other liver problems are uncommon and may affect up to 1 in 100 people.

If you have either of these signs of liver problems:

• yellowing of the skin or the whites of

  the eyes (jaundice)

  • unusually dark-coloured urine è tell your doctor immediately. Bleeding or bruising after you stop treatment

Within two weeks of stopping Revolade, your blood platelet count will usually drop back down to what it was before starting Revolade. The lower platelet count may increase the risk of bleeding or bruising. Your doctor will check your platelet count for at least 4 weeks after you stop taking Revolade.

è Tell your doctor if you have any bleeding or bruising after stopping Revolade.

Some people have bleeding in the digestive system after they stop taking peginterferon, ribavirin, and Revolade. Symptoms include:

• black tarry stools (discoloured bowel movements are a uncommon side effect that may affect up to 1 in 100 people)
• blood in your stools
• vomiting blood or something that looks like coffee grounds

è Tell your doctor immediately if you have any of these symptoms. The following side effects have been reported to be associated with treatment with Revolade in adult patients with ITP:

Very common side effects

These may affect more than 1 in 10 people:

• common cold
• feeling sick (nausea)
• diarrhoea
• cough
• infection in the nose, sinuses, throat and upper airways (upper respiratory tract infection)
• back pain

Very common side effects that may show up in blood tests:

• increased liver enzyme alanine aminotransferase (ALT)

Common side effects

These may affect up to 1 in 10 people:

• muscle pain, muscle spasm, muscle weakness
• bone pain
• heavy menstrual period
• sore throat and discomfort when swallowing
• eye problems including abnormal eye test, dry eye, eye pain and blurred vision
• vomiting
• flu (influenza)
• cold sore
• pneumonia

• irritation and inflammation (swelling)

  of the sinuses

• inflammation (swelling) and infection of the tonsils,
• infection of the lungs, sinuses, nose and throat
• inflammation of the gum tissue
• loss of appetite
• feeling of tingling, prickling or numbness, commonly called “pins and needles”
• decreased skin sensations
• feeling drowsy
• ear pain
• pain, swelling and tenderness in one of your legs (usually the calf) with warm skin in the affected area (signs of a blood clot in a deep vein)
• localised swelling filled with blood from a break in a blood vessel (haematoma)
• hot flushes
• mouth problems including dry mouth, sore mouth, sensitive tongue, bleeding gums, mouth ulcers
• runny nose
• toothache
• abdominal pain
• abnormal liver function
• skin changes including excessive sweating, itching bumpy rash, red spots, changes in appearance of the skin
• hair loss

• foamy, frothy or bubbly-looking urine

  Revolade^®

  300146905 GB

2 of 2 (signs of protein in urine)

• high temperature, feeling hot
• chest pain
• feeling weak
• problems sleeping, depression
• migraine
• decreased vision
• spinning sensation (vertigo)
• digestive wind/gas

Common side effects that may show up in blood test:

• decreased number of red blood cells

  (anaemia)

• decreased number of platelets

  (thrombocytopenia)

• decreased number of white blood cells
• decreased haemoglobin level
• increased number of eosinophils

• increased number of white blood

  cells (leukocytosis)

• increased levels of uric acid
• decreased levels of potassium
• increased levels of creatinine

• increased levels of alkaline

  phosphatase

• increased liver enzyme aspartate

  aminotransferase (AST)

• increased blood bilirubin (a

  substance produced by the liver)

• increased levels of some proteins Uncommon side effects

These may affect up to 1 in 100 people:

• allergic reaction

• interruption of blood supply to part

  of the heart

• sudden shortness of breath,

  especially when accompanied with sharp pain in the chest and /or rapid breathing, which could be signs of a blood clot in the lungs (see ‘Higher risk of blood clots’ earlier in section 4)

• the loss of function of part of the

  lung caused by a blockage in the lung artery

• possible pain, swelling, and/or

  redness around a vein which could be signs of blood clot in a vein

• yellowing of the skin and/or

  abdominal pain which could be signs of a blockage in the bile tract, lesion on liver, liver damage due to inflammation (see ‘Liver problems’ earlier in section 4)

• liver injury due to medication

• heart beating faster, irregular

  heartbeat, bluish discolouration of the skin, disturbances of heart rhythm (QT prolongation) which could be signs of a disorder related to the heart and the blood vessels

• blood clot
• flushing

• painful swollen joints caused by uric

  acid (gout)

• lack of interest, mood changes,

  crying that is difficult to stop, or occurs at unexpected times

• problems with balance, speech and

  nerve function, shaking

• painful or abnormal skin sensations
• paralysis on one side of the body
• migraine with aura
• nerve damage

• dilation or swelling of blood vessels

  that cause headache

• eye problems including increased

  production of tears, cloudy lens in the eye (cataract), bleeding of the retina, dry eyes

• problems with the nose, throat and

  sinuses, breathing problems when sleeping

• mouth and throat blisters/sores
• loss of appetite

• digestive system problems including

  frequent bowel movements, food poisoning, blood in stool, vomiting of blood

• rectal bleeding, change in stool

  colour, abdominal bloating, constipation

• mouth problems, including dry or

  sore mouth, tongue pain, bleeding gums, discomfort in mouth

• sunburn
• feeling hot, feeling anxious
• redness or swelling around a wound

• bleeding around a catheter (if

  present) into the skin

• sensation of a foreign body

• kidney problems including

  inflammation of the kidney, excessive urination at night, kidney failure, white cells in urine

  • cold sweat
  • generally feeling unwell
  • infection of the skin

  • skin changes including skin

    discolouration, peeling, redness, itching and sweating

  • muscular weakness
  • cancer of rectum and colon Uncommon side effects that may show up in laboratory tests:

  • changes in the shape of red blood

    cells

  • presence of developing white blood

    cells which may be indicative of certain diseases

  • increased number of platelets
  • decreased levels of calcium

  • decreased number of red blood

    cells (anaemia) caused by excessive destruction of red blood cells (haemolytic anaemia)

  • increased number of myelocytes
  • increased band neutrophils
  • increased blood urea
  • increased levels of protein in urine
  • increased levels of blood albumin
  • increased levels of total protein
  • decreased levels of blood albumin
  • increased pH of urine
  • increased level of haemoglobin The following additional side effects have been reported to be associated with treatment with Revolade in children (aged 1 to 17 years) with ITP:

If these side effects become severe, please tell your doctor, pharmacist or nurse.

Very common side effects

These may affect more than 1 in 10 children:

• infection in the nose, sinuses, throat

  and upper airways, common cold (upper respiratory tract infection)

• diarrhoea
• abdominal pain
• cough
• high temperature
• feeling sick (nausea)

Common side effects

These may affect up to 1 in 10 children:

• difficulty in sleeping (insomnia)
• toothache
• pain in the nose and throat
• itchy, runny or blocked nose

• sore throat, runny nose, nasal

  congestion and sneezing

• mouth problems including dry

  mouth, sore mouth, sensitive tongue, bleeding gums, mouth ulcers The following side effects have been reported to be associated with treatment with Revolade in combination with peginterferon and ribavirin in patients with HCV: Very common side effects

These may affect more than 1 in 10 people:

• headache
• loss of appetite
• cough
• feeling sick (nausea), diarrhoea
• muscle pain, muscle weakness
• itching
• feeling tired
• fever
• unusual hair loss
• feeling weak
• flu-like illness
• swelling in the hands or feet
• chills

Very common side effects that may show up in blood tests:

• decreased number of red blood cells

  (anaemia)

Common side effects

These may affect up to 1 in 10 people:

• infection of the urinary system

• inflammation of the nasal passages,

  throat and mouth, flu-like symptoms, dry mouth, sore or inflamed mouth, toothache

• weight loss

• sleep disorders, abnormal

  drowsiness, depression, anxiety

  • dizziness, problems with attention

    and memory, change in mood

  • decreased brain function further to

    liver injury

  • tingling or numbness of the hands

    or feet

  • fever, headache

  • eye problems, including cloudy

    lens in the eye (cataract), dry eye, small yellow deposits in the retina, yellowing of the whites of the eye

  • bleeding of the retina
  • spinning sensation (vertigo)

  • fast or irregular heartbeat

    (palpitations), shortness of breath

  • cough bringing up phlegm, runny

    nose, flu (influenza), cold sore, sore throat and discomfort when swallowing

  • digestive system problems, including

    vomiting, stomach pain, indigestion, constipation, swollen stomach, taste disturbances, piles (haemorrhoids), stomach pain/discomfort, swollen blood vessels and bleeding in the gullet (oesophagus)

  • toothache

  • liver problems, including tumour

    in the liver, yellowing of the whites of the eyes or skin (jaundice), liver injury due to medication (see ‘Liver problems’ earlier in section 4)

  • skin changes, including rash, dry

    skin, eczema, redness of the skin, itching, excessive sweating, unusual skin growths, hair loss

  • joint pain, back pain, bone pain, pain

    in extremities (arms, legs, hands or feet), muscle spasms

  • irritability, generally feeling unwell,

    skin reaction such as redness or swelling and pain at the site of injection, chest pain and discomfort, build-up of fluid in the body or extremities causing swelling

  • infection in the nose, sinuses, throat

    and upper airways, common cold (upper respiratory tract infection), inflammation of mucous membrane lining the bronchi

  • depression, anxiety, sleep problems,

    nervousness

Common side effects that may show up in blood tests:

• increased blood sugar (glucose)
• decreased number of white blood cells
• decreased number of neutrophils
• decreased level of blood albumin
• decreased level of haemoglobin

• increased blood bilirubin

  (a substance produced by the liver)

• changes in the enzymes that control

  blood clotting

Uncommon side effects

These may affect up to 1 in 100 people:

• painful urination

• disturbances of heart rhythm

  (QT prolongation)

• stomach flu (gastroenteritis), sore

  throat

• mouth blisters/sores, inflammation

  of the stomach

• skin changes including change in

  colour, peeling, redness, itching, lesion and night sweats

• blood clots in a vein to the liver

  (possible liver and/or digestive system damage)

• abnormal blood clotting in small

  blood vessels with kidney failure

• rash, bruising at the injection site,

  chest discomfort

• decreased number of red blood

  cells (anaemia) caused by excessive destruction of red blood cells (haemolytic anaemia)

• confusion, agitation
• liver failure

The following side effects have been reported to be associated with treatment with Revolade in patients with severe aplastic anaemia (SAA):

If these side effects become severe, please tell your doctor, pharmacist or nurse.

Very common side effects

These may affect more than 1 in 10 people.

• cough

  • headache
  • mouth and throat pain
  • diarrhoea
  • feeling sick (nausea)
  • joint pain (arthralgia)

  • pain in extremities (arms, legs, hands

    and feet)

  • dizziness
  • feeling very tired
  • fever
  • chills
  • itchy eyes
  • blisters in the mouth
  • abdominal pain
  • muscle spasms

Very common side effects that may show up in the blood tests

• abnormal changes to the cells in

  your bone marrow

• increased liver enzyme aspartate

  aminotransferase (AST)

Common side effects

These may affect up to 1 in 10 people.

• anxiety
• depression
• feeling cold
• generally feeling unwell

• eye problems including vision

  problems, blurred vision, cloudy lens in the eye (cataract), spots or deposits in eye (vitreous floaters), dry eye, itchy eye, yellowing of the whites of the eyes or skin

• nose bleed

• digestive system problems including

  difficulty swallowing, mouth pain, swollen tongue, vomiting, loss of appetite, stomach pain/discomfort, swollen stomach, digestive wind/gas, constipation, intestinal motility disorder which can cause

  contipation, bloating, diarrhea and/or above mentioned symptoms, change in stool colour

• fainting

• skin problems including small red or

  purple spots caused by bleeding into the skin (petechiae) rash, itching, hives, skin lesion

• bleeding of the gums
• back pain
• muscle pain
• bone pain
• weakness (asthenia)

• swelling of the lower limbs due to

  the accumulation of fluids

• abnormal colored urine

• interruption in blood supply to

  spleen (splenic infarction)

• runny nose

Common side effects that may show up in the blood tests

• increase in enzymes due to muscle

  breakdown (creatine phosphokinase)

• accumulation of iron in the body

  (iron overload)

• decreased blood sugar levels

  (hypoglycaemia)

• increased blood bilirubin (a

  substance produced by the liver)

• decreased levels of white blood cells Side effects with frequency not known

Frequency cannot be estimated from the available data

• skin discolouration
• darkening of the skin
• liver injury due to medication Reporting of side effects

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects, you can help provide more information on the safety of this medicine.

5. How to store Revolade

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the carton and the blister after EXP.

This medicine does not require any special storage conditions.

Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.

6. Contents of the pack and other information

What Revolade contains

The active substance in Revolade is eltrombopag.

12.5 mg film-coated tablets

Each film-coated tablet contains eltrombopag olamine equivalent to 12.5 mg eltrombopag.

25 mg film-coated tablets

Each film-coated tablet contains eltrombopag olamine equivalent to 25 mg eltrombopag.

50 mg film-coated tablets

Each film-coated tablet contains eltrombopag olamine equivalent to 50 mg eltrombopag.

75 mg film-coated tablets

Each film-coated tablet contains eltrombopag olamine equivalent to 75 mg eltrombopag.

The other ingredients are:

hypromellose, macrogol 400, magnesium stearate, mannitol (E421), microcrystalline cellulose, povidone, sodium starch glycolate, titanium dioxide (E171).

Revolade 12.5 mg and 25 mg film-coated tablets also contain polysorbate 80 (E433).

Revolade 50 mg film-coated tablets also contain iron oxide red (E172) and iron oxide yellow (E172).

Revolade 75 mg film-coated tablets also contain iron oxide red (E172) and iron oxide black (E172).

What Revolade looks like and contents of the pack

Revolade 12.5 mg film-coated tablets are round, biconvex, white, debossed with ‘GS MZ1’ and ‘12.5’ on one side. Revolade 25 mg film-coated tablets are round, biconvex, white, debossed with ‘GS NX3’ and ‘25’ on one side. Revolade 50 mg film-coated tablets are round, biconvex, brown, debossed with ‘GS UFU’ and ‘50’ on one side. Revolade 75 mg film-coated tablets are round, biconvex, pink, debossed with ‘GS FFS’ and ‘75’ on one side. They are supplied in aluminum blisters in a carton containing 14 or 28 film-coated tablets and multipacks containg 84 (3 packs of 28) film-coated tablets).

Not all pack sizes may be available in your country.

Marketing authorisation holder

Novartis Pharmaceuticals UK Limited, 2nd Floor, The WestWorks Building, White City Place,

195 Wood Lane,

London,

W12 7FQ

United Kingdom

Manufacturer

Novartis Pharmaceuticals UK Limited, 2nd Floor, The WestWorks Building, White City Place,

195 Wood Lane,

London,

W12 7FQ

United Kingdom

For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder:

United Kingdom

Novartis Pharmaceuticals UK Ltd. Tel: +44 1276 698370

This leaflet was last revised in July 2025.